Third, we could not evaluate the relation between clinical outcome and the four SCLC subtypes defined by differential expression of the transcription factors ASCL1, NEUROD1, and POU2F3 or low expression of all three transcription factors (SCLC-A, -N, -P, and -I, respectively).41 This evidence concerns the gene ASCL1 and small cell lung carcinoma.